Your body requires the correct levels of growth hormone for efficient and effective metabolism of food, and for correct body composition. The goal of GH therapy is to restore the correct level of GH in patients who present with a GH deficiency.
GH is also necessary for achieving optimum bone density and strength, for regulating the proper ratio between good cholesterol and bad cholesterol, and promoting a correct bodily proportion of muscle to fat. If you are suffering from a GH deficiency, GH supplementary treatment will offer you many benefits.
GH treatment will help you maintain a better body shape. You will achieve a leaner physique, and shed unwanted excess fat through the natural regulatory processes offered by a correct level of GH in the body. Clinical studies have shown a dramatic transformation of fat to lean mass in patients treated for twelve months with GH
GH therapy will reduce your body fat percentage. If you are deficient in endogenous GH, you are very likely carrying more body fat than would be ideal. Supplementing your GH levels will help you to naturally lose that extra fat. Maintaining extra fat is not healthy and corresponds with increased cardiovascular health risks, as well as increased risks for certain cancers. Clinical studies on GH therapy show that people undergoing GH therapy will lose a significant proportion of their total body fat, particularly body fat around the abdomen. Patients show this dramatic fat loss after 12 months of GH treatment. This fat loss occurs equally for people with adult onset or pediatric onset AGHD, who are treated with supplementary GH.
GH treatment will alter your cholesterol ratio for the better. It is important to keep the correct ratio of good (HDL), to bad (LDL) cholesterol, and GH deficient patients often present with abnormally high bad cholesterol. GH therapy will lower bad cholesterol levels and restore the correct balance between good and bad cholesterol. GH therapy will not impact total cholesterol levels, or triglyceride levels. This improved cholesterol ratio will occur for adult onset patients, as well as for pediatric onset patients who were treated with a higher dosage of Hypertropin. Adult onset patients will not well tolerate the higher dosages that are given to child onset patients.
GH treatment will improve the bone and mineral density in the spine. Pediatric onset patients who are treated with higher doses of Hypertropin will show improved mineral density in the spine bone. These child onset patients do not show increased mineral densities in other bones. Adult onset patients given a normal adult onset dosage do not show bone density improvements.